IP Library Granted Patent US 9,682,948
Granted Patent B2
US 9,682,948 · App. 14/437,232 · Granted Jun 20, 2017

7,8-dihydoxyflavone and 7,8-substituted flavone derivatives, compositions, and methods related thereto

Inventor: Keqiang Ye (Lilburn, GA)
Assignee: Emory University
C07D311/30A61K31/352A61K45/06C07D311/28C07D311/36C07D311/38
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,682,948
App. No.
14/437,232
Granted
Jun 20, 2017
Kind
B2
Abstract

In certain embodiments, the disclosure relates to 7,8-dihydoxyflavone and 7,8-substituted flavone derivatives, such as those described by formula provided herein, pharmaceutical compositions, and methods related thereto. In certain embodiments, the disclosure relates to methods of treating or preventing diseases or conditions related to BDNF and TrkB activity, such as psychiatric disorders, depression, post-traumatic stress disorder, and autism spectrum disorders, stroke, Rett syndrome, Parkinson's disease, and Alzheimer's disease by administering effective amounts of pharmaceutical compositions comprising compounds disclosed herein to a subject in need thereof. In certain embodiments, it is contemplated that the 7,8-substituted flavone derivatives disclosed herein are prodrugs of 7,8-dihydoxyflavone and analogs.

Claims (21)

1. A compound having Formula I:

or a salt thereof wherein

X is O;

U and Y are each O, NH, or Nalkyl;

Z is hydrogen;

R 1 is alkyl;

R 2 is alkyl; and

R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , and R 9 are each hydrogen.

2. The compound of claim 1 , wherein U and Y are NH or Nalkyl.

3. The compound of claim 1 , wherein U and Y are oxygen.

4. The compound of claim 1 , selected from:

diethyl (4-oxo-2-phenyl-4H-chromene-7,8-diyl) dicarbonate;

4-oxo-2-phenyl-4H-chromene-7,8-diyl bis(ethylcarbamate); and

4-oxo-2-phenyl-4H-chromene-7,8-diyl bis(dimethylcarbamate), or a salt thereof.

5. A pharmaceutical composition comprising a compound of claim 1 and a pharmaceutically acceptable excipient.

6. The composition of claim 5 , wherein the pharmaceutical composition is in the form of a tablet, capsule, pill, or solution for injection.

7. The compound of claim 1 , wherein the compound is 4-oxo-2-phenyl-4H-chromene-7,8-diyl bis(methylcarbamate) or a salt thereof.

8. A compound selected from:

4-oxo-2-phenyl-4H-chromene-7,8-diyl dipropionate;

4-oxo-2-phenyl-4H-chromene-7,8-diyl bis(2,2-dimethylpropanoate); and

4-oxo-2-phenyl-4H-chromene-7,8-diylbis(3-methylbutanoate), or a salt thereof.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 10, 2018
From: YE, KEQIANG
To: EMORY UNIVERSITY
Reel/Frame 045768/0578 →
CONFIRMATORY LICENSE Recorded May 5, 2015
From: EMORY UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 035575/0465 →
Continuity (3)
Provisional Application 61722339 · Nov 5, 2012
Provisional Application 61845399 · Jul 12, 2013
Related Publication 20150274692A1 · Oct 1, 2015